Business Five-month Hapbee study shows products enhance sleep and recovery Hapbee technology users saw improvements in quality of sleep, length of sleep, reduced restlessness, and reduced time to fall asleep Ryan GarnerMay 10, 2022
Cannabis Consuming cannabis reduces fatigue symptoms: study Up to 37 per cent experienced positive side effects such as feeling active, energetic, "frisky" or productive Natalia Buendia CalvilloMay 9, 2022
Canada Canadian government to grant $3M for psilocybin research studies The aim is to expand the evidence base on psilocybin-assisted psychotherapy to inform practical policies and regulations Natalia Buendia CalvilloMay 5, 2022
Analysis How can the cannabis industry meet the U.N.’s sustainable development goals? Report outlines environmental, social and governance (ESG) priorities for the emerging global industry Ryan GarnerMay 5, 2022
Culture Numinus announces Music as Medicine event series Series of concerts across the U.S. and Canada will explore music’s role in psychedelic-assisted therapy Ryan GarnerMay 3, 2022
Business Canadian cannabis sales dropped nearly 3% to $336M in February Nationwide cannabis sales declined for the second consecutive month to start 2022 Ryan GarnerApril 29, 2022
Analysis U.S. legal and illicit cannabis sales totalled US$97 billion in 2021: report A new report by New Frontier Data estimated that U.S. cannabis sales exceeded spirits (US$86 billion) last year, while matching spending on beer Ryan GarnerApril 20, 2022
Medical and Pharmaceutical Delic Labs granted permission to study psychedelics including LSD, MDMA The Vancouver-based research lab aims to increase understanding of the medical applications of psychedelic compounds Ryan GarnerApril 15, 2022
Medical and Pharmaceutical Psilocybin temporarily disrupts stages of the sleep cycle : study But whether or not the disruption helps with the substance's antidepressant properties still needs further research Natalia Buendia CalvilloApril 11, 2022
Business 92% of patients report improvements in chronic pain after using cannabis oil: Khiron study The study also found that seven out of ten patients did not suffer from adverse effects Natalia Buendia CalvilloApril 5, 2022